Form D/A — Inmedix, Inc.
0001851853-26-000001 · filed Oct 22, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06c
- Reported offering amount
- $5,000,000
- Reported amount sold
- $4,009,945
- Minimum investment
- $50,000
- Investors
- 34
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Inmedix, Inc.
- CIK
- 1851853
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 17837 FIRST AVENUE SOUTH, #6
NORMANDY PARK, WA 98148 - Phone
- 2064125347
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Andrew Holman, M.D. · Executive OfficerNormandy Park, WA Find on LinkedIn ↗
-
Steven Daly, M.S., M.B.A. · DirectorNormandy Park, WA Find on LinkedIn ↗
-
Bernie Tobin · DirectorNormandy Park, WA Find on LinkedIn ↗
-
Leroy Hood, M.D., Ph.D. · DirectorNormandy Park, WA Find on LinkedIn ↗
-
Kevin Tracey, M.D. · DirectorNormandy Park, WA Find on LinkedIn ↗
-
Ryan Sullivan, Ph.D. · DirectorNormandy Park, WA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗